Literature DB >> 8910766

Structural requirements for agonist activity of a murine interferon-gamma peptide.

B E Szente1, I J Weiner, M J Jablonsky, N R Krishna, B A Torres, H M Johnson.   

Abstract

We have demonstrated previously that murine interferon-gamma (MuIFN-gamma) binds to the extracellular domain of the receptor alpha chain through its N-terminus and subsequently to the cytoplasmic domain of the receptor via its C-terminus. Binding of the C-terminus to the cytoplasmic domain of the receptor is thought to occur following endocytosis of the IFN-gamma-receptor complex. In fact, the MuIFN-gamma C-terminus peptide, MuIFN-gamma (95-133), has full agonist activity on macrophages where it is internalized through pinocytosis. Here we examine the structural elements required for the agonist activity of MuIFN-gamma (95-133). Disruption of the alpha helical structure of the peptide by proline substitutions or truncation of the helix resulted in significant loss of binding or loss of antiviral activity or both and induction of MHC class II molecules. Further, removal of the polycationic sequence RKRKR in the tail beyond the helical structure also resulted in loss of agonist activity. Thus, we have isolated the functional site on MuIFN-gamma to the C-terminus and have shown that its helical structure and polycationic tail are required for binding to the cytoplasmic domain of the receptor and induction of biologic activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910766     DOI: 10.1089/jir.1996.16.813

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

1.  Interferon gamma is recognised by importin alpha/beta: enhanced nuclear localising and transactivation activities of an interferon gamma mimetic.

Authors:  Alex J Fulcher; Chulbul M I Ahmed; Ezra N Noon-Song; Rain Y Q Kwan; Prem S Subramaniam; Howard M Johnson; David A Jans
Journal:  FEBS Lett       Date:  2008-04-09       Impact factor: 4.124

2.  Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.

Authors:  P C Melby; V V Tryon; B Chandrasekar; G L Freeman
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 3.  Steroid-like signalling by interferons: making sense of specific gene activation by cytokines.

Authors:  Howard M Johnson; Ezra N Noon-Song; Kaisa Kemppainen; Chulbul M Ahmed
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

4.  Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.

Authors:  Chulbul M I Ahmed; Marjorie A Burkhart; Prem S Subramaniam; Mustafa G Mujtaba; Howard M Johnson
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 5.  Structural conservation of interferon gamma among vertebrates.

Authors:  Ram Savan; Sarangan Ravichandran; Jack R Collins; Masahiro Sakai; Howard A Young
Journal:  Cytokine Growth Factor Rev       Date:  2009-03-05       Impact factor: 7.638

6.  Controlling Nuclear Jaks and Stats for Specific Gene Activation by Ifn γ and Other Cytokines: A Possible Steroid-like Connection.

Authors:  Howard M Johnson; Ezra Noon-Song; Chulbul M Ahmed
Journal:  J Clin Cell Immunol       Date:  2011-09-03

7.  Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy.

Authors:  Chulbul M Ahmed; Ezra N Noon-Song; Kaisa Kemppainen; Massimo P Pascalli; Howard M Johnson
Journal:  J Neuroimmunol       Date:  2012-10-27       Impact factor: 3.478

8.  HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion.

Authors:  Kenneth G Frey; Chulbul M I Ahmed; Rea Dabelic; Lindsey D Jager; Ezra N Noon-Song; S Mohammad Haider; Howard M Johnson; Nancy J Bigley
Journal:  J Immunol       Date:  2009-06-19       Impact factor: 5.422

9.  IFN signaling: how a non-canonical model led to the development of IFN mimetics.

Authors:  Howard M Johnson; Ezra Neptune Noon-Song; Rea Dabelic; Chulbul M Ahmed
Journal:  Front Immunol       Date:  2013-07-25       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.